Here are four high-yield blue-chip pharmaceutical stocks positioned to outperform and offer huge total return potential.

The U.S. was non-committal on whether its baseline tariff would stay at 10% in talks last week, trade minister Gan Kim Yong said at a conference on Tuesday. Gan visited the U.S. last week to discuss ...

Celltrion Inc., a leading South Korean biopharmaceutical company, said Tuesday it has been selected as the preferred bidder ...

By Padmanabhan Ananthan (Reuters) -West Pharmaceutical raised its annual profit forecast and trimmed its estimates for tariff impact on Thursday, sending the medical equipment maker's shares up 24% in ...

The U.S. was non-committal on whether its baseline tariff on Singaporean goods would stay at 10% in talks last week, Singapore's trade minister Gan Kim Yong said at a conference on Tuesday. Gan, who ...

President Donald Trump said Tuesday he’s imposing a new 50% tariff on all copper. However, it’s unclear when the new tariff ...

Despite being significantly lower than the 200% rate threatened by Trump, the deal is set to ramp up drug costs by billions.

Pharma firms are calling for clarity on tariffs imposed under the new U.S.-EU trade agreement, as analysts warn that punitive ...

President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even ...

Americans cannot absorb billions in added drug price hikes as a result of ill-designed and poorly timed tariff increases.